EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $147,228 | -33.6% | 20,031 | -6.4% | 0.00% | -33.3% |
| Q1 2023 | $221,714 | -65.0% | 21,401 | -60.1% | 0.00% | -25.0% |
| Q4 2022 | $633,252 | -12.4% | 53,620 | +55.7% | 0.00% | -60.0% |
| Q3 2022 | $723,000 | -33.5% | 34,440 | -1.7% | 0.01% | -28.6% |
| Q2 2022 | $1,088,000 | -35.8% | 35,048 | -15.2% | 0.01% | -22.2% |
| Q1 2022 | $1,696,000 | -8.5% | 41,313 | -3.1% | 0.02% | -5.3% |
| Q4 2021 | $1,853,000 | – | 42,628 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |